(lp0
S'Stock Overview: Moving Average Check on Hemispherx Biopharma Inc  Rives Journal - 14 hours ago In terms of moving averages for Hemispherx Biopharma Inc , the 200-day is currently at 1.01, the 50-day is 0.51, and the 7-day is resting at 0.54.'
p1
aS"Breaking Down The Hemispherx BioPharma, Inc  Catalsysts Insider Financial - Feb 3, 2017 Hemispherx BioPharma, Inc  took a hit of more than 30% at the end of this week, on the company's announcement that it is set to raise $1 million by way of a registered direct offering .HEMISPHERX BIOPHARMA, INC.  Files An 8-K Entry into a Material ... - Market Exclusive"
p2
aS'Hemispherx Biopharma Announces 1-for-12 Reverse Stock Split GlobeNewswire  - Aug 17, 2016 Hemispherx Biopharma, Inc. is an advanced specialty pharmaceutical company engaged in the manufacture and clinical development of new drug entities for treatment of seriously debilitating disorders.'
p3
aS'Insiders Are Buying Hemispherx Biopharma, Inc.  The Herald - 22 hours ago According to the latest filings, corporate insiders at Hemispherx Biopharma, Inc.  have increased their position in the stock by 209.80% over the past 6 months.Positive Press Coverage Likely to Impact Hemispherx BioPharma  Share Price - Chaffey BreezeThe Hemispherx BioPharma  Earning Somewhat Positive Media Coverage ... - Petro Global News 24'
p4
aS"Price Target Estimates for: Hemispherx Biopharma, Inc.  StandardOracle - Apr 12, 2017 Hemispherx Biopharma, Inc.  added 5.66% to reach $0.56 in the previous trading session. Overall, 1.41 Million shares exchanged hands versus its average trading volume of 256.02 Million shares.A Look at Hemispherx BioPharma, Inc 's Financial Scorecard - StockNewsUnionHemispherx BioPharma, Inc  CEO Purchases $100000.00 in Stock - The Cerbat Gem"
p5
aS'Hemispherx BioPharma Inc  Making A Comeback Insider Financial - Mar 8, 2016 Hemispherx BioPharma Inc  is one biotech name that has desperately been in need of few changes. It looks like investors are going to get the turnaround needed after the company finally fired longtime Chairman &amp; CEO Dr.'
p6
aS'Company Update : Hemispherx BioPharma, Inc Meets Ampligen Sales ... Smarter Analyst - Mar 6, 2017 Hemispherx BioPharma, Inc  announced today that it has met a major milestone, the commencement of sales of recently manufactured Ampligen in international programs.'
p7
aS"Hemispherx BioPharma CEO Talks About Ampligen, Alferon's Potential Benzinga - Jan 3, 2017 Hemispherx BioPharma, Inc  is a nano-cap biopharmaceutical research and development company that focuses on the treatment of seriously debilitating disorders."
p8
aS"Company Update : Here's Why Hemispherx BioPharma, Inc Shares Are ... Smarter Analyst - Feb 2, 2017 This morning, Hemispherx BioPharma, Inc  announced that it has entered into definitive agreements with several institutional investors for an offering of shares of common stock with gross proceeds of approximately $1 million in a ..."
p9
aS'Hemispherx Biopharma: Catalysts For A Turnaround Seeking Alpha - Jun 10, 2015 Hemispherx Biopharma, Inc.  has been in the news lately for a variety of reasons that may be of interest to investors.'
p10
a.